Science
Mechanism of Action
This compound exerts its anti-inflammatory effects by modulating key cellular pathways, specifically down-regulating NF-κB and STAT3 signaling within human keratinocytes and inhibiting the activation of the NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome. Additionally, it demonstrates antioxidant capabilities through free radical scavenging and restoration of superoxide dismutase activity, alongside an ability to inhibit keratinocyte proliferation.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Cucurbitacin B is heat sensitive and requires refrigeration (0-10°C) for optimal stability. Its generally limited water solubility often necessitates advanced delivery systems, such as nanosuspensions or nanogels, to improve bioavailability, particularly in pharmaceutical applications.
Safety
Safety Profile
Primarily studied for its potent pharmacological activities, Cucurbitacin B has documented reports of high toxicity and a narrow therapeutic window, especially in anti-cancer contexts. While approved as an oral adjuvant therapy in China for certain medical conditions, there is no specific safety assessment from CIR or SCCS for cosmetic use, nor an FDA status for topical cosmetic application.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Cucurbitacin B exhibits promising anti-inflammatory and antioxidant properties in preclinical studies, its noted high toxicity, narrow therapeutic window, and complete lack of cosmetic-specific safety assessments render its use in skincare highly questionable for precision formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources